B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1 (Q39068): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Neoplasia linfoide precursora que é composta por linfoblastos B e apresenta uma translocação entre o gene BCR no cromossomo 22 e o gene ABL1 no cromossomo 9. Isso resulta na produção da proteína de fusão p190 kd ou p210 kd. Apresenta evolução clínica desfavorável. | |||
| description / en | description / en | ||
A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome. | |||
Revision as of 04:22, 13 August 2026
A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2A70.1 |
||
| English | B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1 |
A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome. |
